【里昂：维持华润医药(03320.HK)“跑赢大市”评级 目标价下调至6.5港元】智通财经APP获悉，里昂发布研报称，维持华润医药(03320.HK)“跑赢大市”评级，基于中期业绩表现，将2026至2028年收入预测分别下调3.4%、7%及9.7%，当中制药业务销售预测分别下调7.8%、14.3%及19.6%，净利润预测下调6.4%、10.8%及20.1%，目标价由7.2港元下调至6.5港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.